5AM Ventures
5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies. The firm primarily invests in private therapeutic companies, with a focus on early-stage Series A investments. Additionally, 5AM Ventures has a public equity strategy that targets small and mid-cap public and later-stage private biotech and life science companies. The firm is committed to supporting companies that are working to solve important healthcare needs through cutting-edge breakthroughs in medicine and science.
5AM Ventures
What We Do
5AM’s hands-on internal effort to discover, incubate, and fund breakthrough science. They partner with academics and entrepreneurs to establish proof-of-concept data that will enable a Series A Financing.
Geographic Focus
Investment Range
Portfolio
Received a ₤4.1 million award from the Wellcome Trust to advance its neoglycosides portfolio.
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
Received Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease.
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals
#Biopharmaceuticals